News in brief

Colorcon and Applied DNA Sciences sign tech MOU

By Staff reporter

- Last updated on GMT


Related tags Pharmacology Science Counterfeit

Colorcon Inc. and Applied DNA Sciences Inc. have teamed up to commercialize an on-dose traceability platform they say will help combat counterfeits.

The memorandum of understanding – which is expected to be followed by a definitive licensing deal – will see Colorcon integrate Applied DNA’s “molecular taggant” technology into its film coating, ink and colour dispersion systems.

Taggants are encoded materials that are impossible to duplicate.

Kelly Boyer, manager of film coating at Colorcon, said, “By incorporating molecular taggants from Applied DNA into our specialty excipients, Colorcon is able to offer a simple and seamless solution to our pharmaceutical and nutraceutical customers to address counterfeiting and product diversion issues​.”

According to Colorcon "This collaboration will commercialize a platform for traceability directly on dose, and is intended to significantly reduce the risks associated with counterfeit and falsified medications entering the drug supply chain.​"

Related news

Show more

Related products

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Understanding the hidden value of quality

Understanding the hidden value of quality

Content provided by Thermo Fisher Scientific – Production Chemicals and Services | 16-Jan-2023 | White Paper

The raw material supply is too vital to leave to chance, and quality-related supply chain activities are cornerstones to your success.

Follow us